Risk of traumatic intracranial haemorrhage is increased in older people exposed to oral anticoagulation with phenprocoumon

Aging Clin Exp Res. 2020 Mar;32(3):441-447. doi: 10.1007/s40520-019-01215-5. Epub 2019 May 17.

Abstract

Background: Hospital admissions resulting from traumatic intracranial haemorrhages (TIH) in older people are increasing. There are concerns regarding an increased risk of a TIH in people taking oral anticoagulants (OAC) like phenprocoumon.

Aims: The aim of this study was to estimate the incremental risk of a TIH associated with OAC in older people. Furthermore, this study explored differences in risk according to functional status.

Methods: The study took data from a large German health insurance provider and combined hospital diagnoses with data regarding drug dispensing to estimate rates of a TIH in people with and without exposure to phenprocoumon. Analyses were stratified by sex and by severe functional impairment as disclosed by the long-term care insurance provider.

Results: Overall, exposure to OAC resulted in 2.7 times higher rates of TIH. People with severe functional impairment had a higher baseline risk of TIH than people without severe functional impairment. However, the incremental risk in those exposed to OAC was similar among people with and without severe functional impairment (standardised incidence rate difference 15.73 (95% CI 7.84; 23.61) and 12.10 (95% CI 9.63; 14.57) per 10,000 person-years, respectively).

Conclusions: OAC increases the risk of TIH considerably. The incremental risk of TIH in those exposed to OAC is comparable between people with and without severe functional impairment. The presence of severe functional impairment per se should not exclude such patients from the potential benefits of OAC. For now, the prescription should be personalized based on individual fall risk factors and risk-taking behaviour.

Keywords: Anticoagulation; Elderly; Head injury; Intracranial haemorrhage; Trauma.

MeSH terms

  • Accidental Falls*
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Case-Control Studies
  • Female
  • Humans
  • Intracranial Hemorrhage, Traumatic / epidemiology*
  • Intracranial Hemorrhage, Traumatic / etiology
  • Male
  • Middle Aged
  • Phenprocoumon / administration & dosage
  • Phenprocoumon / adverse effects*
  • Physical Functional Performance
  • Risk Assessment

Substances

  • Anticoagulants
  • Phenprocoumon